Press release
Atopic Dermatitis Competitive Landscape Report (Updated) | Eli Lilly and Company, Vanda Pharmaceuticals, Arcutis Biotherapeutics, Suzhou Connect Biopharmaceuticals, Dermavant Sciences Inc.
Atopic dermatitis Market
Key Takeaways from the Atopic Dermatitis Competitive Landscape Report
• DelveInsight's Atopic Dermatitis report depicts a robust space with 100+ Atopic Dermatitis companies working to develop 110+ pipeline therapies for Atopic Dermatitis treatment.
• The leading Atopic Dermatitis Companies working in the market include Eli Lilly and Company, Vanda Pharmaceuticals, Arcutis Biotherapeutics, Suzhou Connect Biopharmaceuticals, Dermavant Sciences, Inc., Suzhou Zelgen Biopharmaceuticals, Reistone Biopharma, Kyowa Kirin, Cara Therapeutics, Kangstem Biotech, Arena Pharmaceuticals, Bellus Health, Tioga Pharmaceutical, BioMimetix, Botanix Pharmaceuticals, AOBiome, Aclaris Therapeutics, Asana BioSciences, Sanofi, Horizon Therapeutics, Evommune, Celgene Corporation, Allakos Inc., Bayer, Alphyn Biologics, Argenx, Shulov Innovate for Science, Teres Bio, Qurient Co, Sun Pharmaceutical, Pfizer, Ichnos Sciences, Shaperon, Pyramid Bioscience, selection, GSK, Avixgen Inc., Brexogen, Fresh Tracks Therapeutics, Yuhan Corporation, Ribon Therapeutics, Biosion, HK inno.N Corporation, NovaCell Technology Inc., Inmagene Biopharmaceuticals, and others.
• Promising Atopic Dermatitis Therapies in the various stages of development include Baricitinib, si-544, Lebrikizumab, MEDI9929, Dupilumab, Midazolam, Omeprazole, KP-413 Ointment, and others.
• December 2023: Sanofi announced a study of Phase 2 clinical trials for SAR444656 (KT-474). This is a multinational, multicenter, double-blind, placebo-controlled, parallel-group Phase 2, 3-arm study in adult participants with moderate to severe AD who are inadequately controlled with topical therapies or for whom such topical therapies are inadvisable and who are candidates for systemic therapy.
• December 2023: RAPT Therapeutics Inc. announced a study of Phase 2 clinical trials for RPT193. A Phase 2 Study to Evaluate the Efficacy and Safety of RPT193 as Monotherapy in Adults With Moderate-to-Severe Atopic Dermatitis.
Request a sample and discover the recent advances in Atopic Dermatitis Drugs @ Atopic Dermatitis Competitive Landscape Report- https://www.delveinsight.com/report-store/atopic-dermatitis-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Atopic Dermatitis report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Atopic Dermatitis report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Atopic Dermatitis Overview
Atopic dermatitis (AD) also called eczema, is a chronic condition and the most common type of skin inflammation that usually starts in early childhood, but can occur at any age and can be recurrent or persistent throughout life. In the word 'dermatitis,' 'derm' means 'skin' and 'itis' means 'inflammation.' Thus, dermatitis is a skin inflammation characterized by itchiness, redness and a rash caused by genetics, an overactive immune system, infections, allergies, and irritating substances. Half of the patients with moderate-to-severe eczema also have asthma, hay fever (allergic rhinitis), and food allergies. It is the most common chronic skin disease in children.
Find out more about Atopic Dermatitis Analytical Perspective: In-depth Commercial Assessment @ Atopic Dermatitis Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/atopic-dermatitis-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Atopic Dermatitis Companies and Therapies
• Incyte: OPZELURA
• LEO Pharma: ADTRALZA
• Cara Therapeutics Difelikefalin
• Kyowa Kirin: KHK4083
• Bayer: Zabedosertib
• Alphyn Biologics: AB-101a
• VYNE Therapeutics: FMX114
• MatriSys Bioscience: MSB-0221
Atopic Dermatitis Competitive Landscape: Analytical Perspective
The Atopic Dermatitis report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Atopic dermatitis Report Assessment
• Atopic Dermatitis Company Analysis
• Atopic Dermatitis Therapeutic Assessment
• Atopic Dermatitis Pipeline Assessment
• Inactive Atopic Dermatitis Drugs assessment
• Atopic Dermatitis Unmet Needs
Learn more about the emerging Atopic Dermatitis Competitive Landscape @ Atopic Dermatitis Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/atopic-dermatitis-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Atopic Dermatitis Report
• Coverage- Global
• Atopic Dermatitis Companies- Eli Lilly and Company, Vanda Pharmaceuticals, Arcutis Biotherapeutics, Suzhou Connect Biopharmaceuticals, Dermavant Sciences, Inc., Suzhou Zelgen Biopharmaceuticals, Reistone Biopharma, Kyowa Kirin, Cara Therapeutics, Kangstem Biotech, Arena Pharmaceuticals, Bellus Health, Tioga Pharmaceutical, BioMimetix, Botanix Pharmaceuticals, AOBiome, Aclaris Therapeutics, Asana BioSciences, Sanofi, Horizon Therapeutics, Evommune, Celgene Corporation, Allakos Inc., Bayer, Alphyn Biologics, Argenx, Shulov Innovate for Science, Teres Bio, Qurient Co, Sun Pharmaceutical, Pfizer, Ichnos Sciences, Shaperon, Pyramid Bioscience, selection, GSK, Avixgen Inc., Brexogen, Fresh Tracks Therapeutics, Yuhan Corporation, Ribon Therapeutics, Biosion, HK inno.N Corporation, NovaCell Technology Inc., Inmagene Biopharmaceuticals, and others.
• Atopic Dermatitis Therapies- Baricitinib, si-544, Lebrikizumab, MEDI9929, Dupilumab, Midazolam, Omeprazole, KP-413 Ointment, and others.
• Atopic Dermatitis Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Atopic Dermatitis Product Developmental Activities, Visit @ Atopic Dermatitis Research and Development Activities- https://www.delveinsight.com/sample-request/atopic-dermatitis-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Atopic Dermatitis Executive Summary
3. Atopic dermatitis: Overview
4. Atopic dermatitis -Analytical Perspective: In-depth Commercial Assessment
5. Atopic Dermatitis Competitive Landscape
6. Atopic Dermatitis Therapeutic Assessment
7. Atopic dermatitis: Company and Product Profiles (Marketed Therapies)
8. Incyte
9. OPZELURA
10. Atopic dermatitis: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. Cara Therapeutics
13. Difelikefalin
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Bayer
17. Zabedosertib
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. Merck Sharp & Dohme LLC
21. MK-6194
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Company Name
25. Product Name
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Atopic dermatitis Unmet needs
29. Atopic dermatitis Market drivers and barriers
30. Appendix
For further information on the Atopic Dermatitis Report @ Atopic Dermatitis Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/atopic-dermatitis-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Reports in 2024
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Cancer Therapy Market- https://www.delveinsight.com/report-store/cancer-therapy-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Methicillin-resistant Staphylococcus Aureus Mrsa Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
Rhinosinusitis Market- https://www.delveinsight.com/report-store/rhinosinusitis-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Wilms Tumor Market- https://www.delveinsight.com/report-store/wilms-tumor-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Cold Agglutinin Disease Market- https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Radiation Dermatitis Market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
Synovial Sarcoma Market- https://www.delveinsight.com/report-store/synovial-sarcoma-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Diabetic Nephropathy Market- https://www.delveinsight.com/report-store/diabetic-nephropathy-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Pcsk9 Inhibitors Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Chemotherapy Induced Neutropenia Market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Primary Biliary Cholangitis Market- https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Membranous Nephropathy Market- https://www.delveinsight.com/report-store/membranous-nephropathy-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Post Operative Pain Market- https://www.delveinsight.com/report-store/postoperative-pain-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Axillary Hyperhidrosis Market- https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Competitive Landscape Report (Updated) | Eli Lilly and Company, Vanda Pharmaceuticals, Arcutis Biotherapeutics, Suzhou Connect Biopharmaceuticals, Dermavant Sciences Inc. here
News-ID: 3573280 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Atopic
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
